Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 79

Ecovacs to clean up on Shanghai Stock Exchange

IDG Capital-backed robot vacuum producer Ecovacs has filed for a flotation on the Shanghai Stock Exchange.

Mar 1, 2017

Alteryx files for $75m IPO

Data analytics provider Alteryx has filed for an initial public offering on the New York Stock Exchange, providing an exit to Thomson Reuters and Sapphire Ventures.

Feb 28, 2017

Next Games to score $31.7m IPO

The mobile game developer is seeking a flotation in Helsinki, providing an exit to Lionsgate, AMC, IDG Ventures and IDG Capital.

Feb 27, 2017

Jounce bounces to $102m IPO

Celgene and Pharmstandard scored exits as part of an initial public offering in which immuno-oncology company Jounce floated above its range.

Jan 30, 2017

AnaptysBio snaps $75m in initial public offering

AnaptysBio, which filed for the IPO in 2015, has gone public in an offering that will give long-term investor Novo an exit.

Jan 27, 2017

ObsEva reports $97m IPO

Novo and Merck Group have exited ObsEva in an offering that involved the reproductive health treatment developer floating in the middle of its range.

Jan 27, 2017

Knightscope eyes $20m from public offering

Knightscope, backed by NTT Docomo, Konica Minolta and Flextronics, has opted for a regulation A+ offering that enables members of the public to buy shares.

Jan 13, 2017

G-bits wins $138m in IPO

The game producer's Shanghai Stock Exchange flotation has provided exits to shareholders including IDG Capital Partners and Ping An Insurance.

Jan 5, 2017

Meitu IPO tops $600m

The photo modification app developer raised $629m in an initial public offering that provided Sina Weibo, Foxconn and IDG Capital Partners with exits.

Dec 15, 2016

SportsHero to trade on ASX

The company will conduct a reverse merger with its shareholder Nevada Iron to float on the Australian Stock Exchange.

Dec 9, 2016
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here